Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone

AAPS PharmSciTech

Volumn 4, Issue 2, 2003, Pages

  Capan, Yilmaz ^a   Jiang, Ge ^b   Giovagnoli, Stefano ^c   Na, Kyu Heum ^d   DeLuca, Patrick P ^e  

^a HACETTEPE UNIVERSITY   (Turkey)

^b BD Technologies   (United States)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Dong A Pharmaceutical Company   (South Korea)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Composite microspheres; Human growth hormone; Microspheres; Protein delivery

Indexed keywords

HETASTARCH; MANNITOL; MICROSPHERE; POLYGLACTIN; RECOMBINANT GROWTH HORMONE; DRUG CARRIER; HUMAN GROWTH HORMONE; POLYGLYCOLIC ACID;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG RELEASE; DRUG RESEARCH; DRUG STABILITY; ENCAPSULATION; EVAPORATION; FREEZE DRYING; HYDROGEL; INFRARED SPECTROSCOPY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN SECONDARY STRUCTURE; SOLVENT EXTRACTION; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; HUMAN; METHODOLOGY; PROTEIN CONFORMATION;

DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMAN GROWTH HORMONE; HUMANS; MICROSPHERES; POLYGLYCOLIC ACID; PROTEIN CONFORMATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 0141430055     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt040228     Document Type: Article

References (26)

1. Woo BW, Jiang G, Jo YW, DeLuca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res. 2001;18:1600-1606.
2. Schrier JA, DeLuca PP. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery. Pharm Dev Technol. 1999;4:611-621.
3. Okada HY, Heya IT, Ueno H, Ogawa Y, Toguchi H. Pharmacokinetics of once-a-month injectable microspheres of Leuprolide Acetate. Pharm Res. 1991;8:787-791.
4. Hausberger G, DeLuca PP. Characterization of biodegradable poly (D,L-lactide-co-glycolide )polymers and microspheres. J Pharm Biomed Anal. 1995;13:747-760.
5. Li X, Zhang Y, Yan R, et al. Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly (ethylene glycol) microspheres. J Control Release. 2000;68:41-52.
6. Sah H. Protein instability toward organic solvent/water emulsification: implications for protein microencapsulation into microspheres. PDA J Pharm Sci Technol. 1999;-53:10.
7. Johnson O, Cleland JL, Lee HJ, et al. A month-long effect from a single injection of microencapsulated human growth hormone. Nat Med. 1996;2:795-799.
8. Jorgensen JOL. Human growth hormone replacement therapy: pharmacological and clinical aspects. Endocr Rev. 1991;12:189-207.
9. Moller J, Frandsen E, Fisker S, Jorgensen JO, Christiansen JS. Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol. 1996;44:533-539.
10. Fine RN, Kohaut EC, Brown D, Perlman AJ. Growth after recombinant growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatrics. 1994;124:374-382.
11. Ranke, MB. Growth Hormone therapy in Turner syndrome: analysis of long term results. Horm Res. 1995;44:35-41.
12. Weintroth SE, Parenti DM, Simon GL. Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches. Infect Agents Dis. 1995;4:76-94.
13. Cleland JL, Jonson OL, Putney S, Jones AJS. Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development. Adv Drug Deliv Rev. 1997;28:71-84.
14. Wang N, Wu XS. A novel approach to stabilization of protein drugs in poly (lactide-co-glycolide) microspheres using agarose hydrogel. Int J Pharm. 1998;166:1-14.
15. Pitt CG, Cha Y, Shah SS, Zhu KJ. Blends of PVA and PLGA: control of permeability and degradability of hydrogels by blending. J Control Release. 1992;19:189-200.
16. Huang LK, Mehta RC, De Luca PP. Evaluation of a statistical model for the formation of poly(acryloyl hydroxyethyl starch) microspheres. Pharm Res. 1997;14:475-482.
17. Cleland JL, Jones AJ. Stable formulation of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. Pharm Res. 1996;13(10):1464-1475.
18. Shibuya T, Watanade Y, Nalley KA, Fusco A, Salafsky B. The BCA protein determination system: an analysis of several buffers, incubation temperature and protein standards. J Tokyo Mid College. 1989;47:677-682.
19. Kang F, Singh J. Effect of additives on the release of a model protein from PLGA microspheres. AAPS PharmSciTech. 2001;2(4):article 30.
20. Prestrelski SJ, Tedeschi N, Arakawa T, Carpenter JF. Dehydration-induced conformational changes in proteins and their inhibition by stabilizers. Biophys J. 1993;65:661-671.
21. Yang TH, Dong A, Meyer J, Johnson OL, Cleland JL, Carpenter JF. Use of infrared spectroscopy to assess secondary structure of Human Growth Hormone within biodegradable microspheres. J Pharm Sci. 1999;88:2,161-165.
22. Griebenow K, Klibanov AM. On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J Am Chem Soc. 1996;118:11695-11700.
23. Griebenow K, Klibanov AM. Can conformational changes be responsible for solvent and excipients effects on the catalytic behavior of subtilisin Carlsberg in organic solvents? Biotechnol Bioeng. 1997;53:351-362.
24. Susi H, Byler DM. Resolution enhanced Fourier transform infrared spectroscopy of enzymes. Methods Enzymol. 1986;130:290-311.
25. Carrasquillo KG, Costantino HR, Cordero RA, Hsu CC, Griebenow K. On the structural preservation of recombinant human growth hormone in a dried film of a synthetic biodegradable polymer. J Pharm Sci. 1999;88:2, 166-173.
26. Costantino HR, Carrasquillo KG, Cordero RA,Mumenthaler M, Hsu CC, Griebenow K. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone. J Pharm Sci. 1998;87:11, 1412-1420.